C J Walsh1, T Zaihra2, A Benedetti3,4,5, C Fugère6, R Olivenstein6, C Lemière7,8, Q Hamid6, J G Martin9. 1. Department of Medicine, Institute of Medical Sciences, Keenan Centre for Biomedical Research, Li Ka Shing Knowledge institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada. 2. Department of Mathematics, SUNY-Brockport, Brockport, NY, USA. 3. Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montreal, QC, Canada. 4. Department of Medicine, McGill University, Montreal, QC, Canada. 5. Department of Epidemiology, Biostatistics and Occupational health, McGill University, Montreal, QC, Canada. 6. Montreal Chest Institute and the Meakins-Christie Laboratories, Montreal, QC, Canada. 7. Research Centre, Hôpital du Sacré-Cœur de, Montreal, QC, Canada. 8. Faculty of Medicine, University de Montreal, Montreal, QC, Canada. 9. Department of Medicine, McGill University, Montreal, QC, Canada. james.martin@mcgill.ca.
Abstract
BACKGROUND: Airway inflammatory phenotyping is increasingly applied to subjects with asthma. However, its relationship to clinical outcomes in difficult asthma is incompletely elucidated. OBJECTIVE: The goal of our study was to determine the relationship between exacerbation rates and phenotypes of difficult asthma based on the longitudinal measures of sputum eosinophils and neutrophils. METHODS: Subjects in the longitudinal observational study from two tertiary care centres that completed 1 year of observation and provided at least three sputum samples were classified by inflammatory phenotypes using previously established thresholds. Kaplan-Meier curves and univariable and multivariable Cox proportional hazard models were used to determine the association between inflammatory phenotypes and exacerbation rate. RESULTS: During the study, 115 exacerbations occurred in 73 severe asthmatic subjects. Subjects with the persistently eosinophilic phenotype had a significantly shorter time to first exacerbation and greater risk of exacerbation over a 1-year period than those with the non-eosinophilic phenotype based on the univariable and multivariable Cox proportional hazard model (hazard ratio [HR], 3.24; 95% confidence interval [CI], 1.35-7.72; adjusted HR, 3.90; 95% CI, 1.34-11.36). No significant differences in time to first exacerbation or exacerbation risk over a 1-year period were observed among the neutrophilic phenotypes. CONCLUSIONS: The persistent eosinophilic phenotype is associated with increased exacerbation risk compared with the non-eosinophilic phenotype in severe asthma. No differences in time to first exacerbation or exacerbation risk over a 1-year period were detected among neutrophilic phenotypes.
BACKGROUND: Airway inflammatory phenotyping is increasingly applied to subjects with asthma. However, its relationship to clinical outcomes in difficult asthma is incompletely elucidated. OBJECTIVE: The goal of our study was to determine the relationship between exacerbation rates and phenotypes of difficult asthma based on the longitudinal measures of sputum eosinophils and neutrophils. METHODS: Subjects in the longitudinal observational study from two tertiary care centres that completed 1 year of observation and provided at least three sputum samples were classified by inflammatory phenotypes using previously established thresholds. Kaplan-Meier curves and univariable and multivariable Cox proportional hazard models were used to determine the association between inflammatory phenotypes and exacerbation rate. RESULTS: During the study, 115 exacerbations occurred in 73 severe asthmatic subjects. Subjects with the persistently eosinophilic phenotype had a significantly shorter time to first exacerbation and greater risk of exacerbation over a 1-year period than those with the non-eosinophilic phenotype based on the univariable and multivariable Cox proportional hazard model (hazard ratio [HR], 3.24; 95% confidence interval [CI], 1.35-7.72; adjusted HR, 3.90; 95% CI, 1.34-11.36). No significant differences in time to first exacerbation or exacerbation risk over a 1-year period were observed among the neutrophilic phenotypes. CONCLUSIONS: The persistent eosinophilic phenotype is associated with increased exacerbation risk compared with the non-eosinophilic phenotype in severe asthma. No differences in time to first exacerbation or exacerbation risk over a 1-year period were detected among neutrophilic phenotypes.
Authors: Annette T Hastie; David T Mauger; Loren C Denlinger; Andrea Coverstone; Mario Castro; Serpil Erzurum; Nijar Jarjour; Bruce D Levy; Deborah A Meyers; Wendy C Moore; Brenda Phillips; Sally E Wenzel; John V Fahy; Elliot Israel; Eugene R Bleecker Journal: J Allergy Clin Immunol Date: 2020-02-05 Impact factor: 10.793
Authors: Marie Godar; Kim Deswarte; Karl Vergote; Michael Saunders; Hans de Haard; Hamida Hammad; Christophe Blanchetot; Bart N Lambrecht Journal: J Allergy Clin Immunol Date: 2018-06-08 Impact factor: 10.793
Authors: Annette T Hastie; David T Mauger; Loren C Denlinger; Andrea Coverstone; Mario Castro; Serpil Erzurum; Nizar Jarjour; Bruce D Levy; Deborah A Meyers; Wendy C Moore; Brenda R Phillips; Sally E Wenzel; John V Fahy; Elliot Israel; Eugene R Bleecker Journal: Am J Respir Crit Care Med Date: 2021-04-01 Impact factor: 21.405
Authors: Matthew J Camiolo; Sagar L Kale; Timothy B Oriss; Marc Gauthier; Anuradha Ray Journal: Curr Opin Immunol Date: 2021-03-24 Impact factor: 7.268
Authors: Xizi Du; Yu Yang; Ming Yang; Lin Yuan; Leyuan Wang; Mengping Wu; Kai Zhou; Wenkai Li; Yang Xiang; Xiangping Qu; Huijun Liu; Xiaoqun Qin; Chi Liu Journal: Int J Biol Sci Date: 2022-01-01 Impact factor: 6.580